Connect with us

Technology

Force Therapeutics Reduces 30-Day Readmissions, New Study Shows

Published

4 hours ago

on

Research demonstrates hospitals using Force Therapeutics care management platform benefit from significantly lower excess readmissions, positioning them for success under TEAM

NEW YORK, Nov. 6, 2024 /PRNewswire/ — Force Therapeutics, the leading orthopedic digital care management platform, announced today the release of new research demonstrating how hospitals that use the platform, compared to those that do not, exhibit much lower excess readmission rates. In addition, within a single organization, sites that do use Force Therapeutics were shown to have substantially lower excess readmission rates compared to sites that do not.

This research stemmed from the recent announcement from Centers for Medicare & Medicaid Services (CMS) surrounding the introduction of the Transforming Episode Accountability Model (TEAM), a new mandatory payment model aimed at reducing costs and improving care quality across five episode categories: lower extremity joint replacements (LEJR), surgical hip/femur fracture treatments (SHFFT), coronary artery bypass grafts (CABG), spinal fusions, and major bowel procedures.

Similar to previous bundled payment models, hospitals mandated to participate in TEAM will be required to maintain 30-day episode spending below a certain target price, subject to care quality adjustments. Those who succeed will receive financial incentives, while those who exceed the target price will be required to issue repayments to CMS. Within this context, excess readmissions–which are associated with significant costs–carry an outsized impact on 30-day episode spending, making it absolutely critical that hospitals work to eliminate avoidable readmissions to the best of their abilities.

The research is based on data obtained from the CMS Hospital Readmission Reduction Program (HRRP) for the period of July 2019 through June 2022. In the first part of the study, all hospitals in the HRRP were grouped into 3 categories: Hospitals that used Force throughout the study time frame, hospitals that used Force during part of the study time frame, and hospitals that have never used Force. Hospitals in the first category demonstrated on average an excess readmission rate of 0.98, reflecting less readmissions than expected based on patient population risk factors, while the other two categories saw excess readmission rates of 1.04 and 1.01. The analysis clearly illustrates how hospitals using Force outmatch their counterparts and benefit from substantially lower readmissions, supporting higher quality care for their patients and lowering their Medicare cost expenditures.

In the second part of the study, one large academic health system was selected for a site by site investigation; two of the organization’s sites had been using Force, while a third site was not. Among the two sites using Force, excess readmission rates stood at 0.94 and 0.87, while the third site not using Force had an excess readmission rate of 1.25. Once again, this data shows how slight variations in care, even between sites within a single hospital system, can lead to drastically different quality of care results. With Force, care standardization at scale minimizes outliers, enabling hospitals to provide smarter value-based care.

“As the beginning of TEAM in January 2026 approaches, our team and partner care organizations are working to ensure that all the components of delivering high-quality value-based care are in place well ahead of time,” said Bronwyn Spira, CEO, Force Therapeutics. “With our platform, hospitals can fully engage their patients to capture important insights remotely, setting the stage for successful post-operative home recoveries and avoiding highly costly and stressful adverse events such as readmissions, despite the increasingly short amount of time these patients spend in the hospital setting.”

Force Therapeutics, says Spira, enables hospitals to comprehensively prepare patients for surgery and offer in-depth virtual support at every step of the recovery journey. Beyond minimizing readmissions, this empowers patients and providers to designate clear patient expectations and enable shared decision making, which has been shown to result in higher patient satisfaction and superior functional outcomes.

This is accomplished through gold-standard pre- and post-operative education to prevent complications (such as infections and blood clots); actionable watchlists to provide visibility into patient progress and enable early intervention; remote monitoring and smart alerts to flag signs of challenging recovery journeys; and direct communication tools to quickly address questions and avoid ED visits. The platform also boasts an unparalleled level of patient engagement and long-term PROMs capture rates, supporting regulatory compliance and quality improvement initiatives.

Access the new study here.

About Force Therapeutics
Force Therapeutics is the leading orthopedic digital care management platform, designed to help clinicians effectively manage patients’ rehabilitation and recovery remotely using evidence-based care pathways. The platform leverages video and digital connections to directly engage non-operative and operative patients at every step of the care journey. Backed by millions of clinically validated patient data points and insights from more than 70 leading healthcare centers across the country, Force Therapeutics is proven to reduce care variation, lower overall costs, maximize care team efficiency, and improve patient outcomes and satisfaction.

View original content to download multimedia:https://www.prnewswire.com/news-releases/force-therapeutics-reduces-30-day-readmissions-new-study-shows-302293425.html

SOURCE Force Therapeutics

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Arjo and Bruin Biometrics conclude distribution agreement, Bruin Biometrics resumes direct sales and marketing of Provizio® SEM Scanner

Published

8 mins ago

on

November 6, 2024

By

LOS ANGELES and LONDON, Nov. 6, 2024 /PRNewswire/ — Today Bruin Biometrics and Arjo announce the immediate transition of direct sales and marketing of the Provizio® SEM Scanner to Bruin Biometrics, following four years of cooperation between the companies.

As communicated earlier this year, the companies decided not to extend the distribution agreement for the Provizio SEM Scanner. Accordingly, and effective today, all sales and marketing of the Provizio SEM Scanner products transition from Arjo to Bruin Biometrics. Both companies remain fully committed to supporting customers throughout the process to ensure a continued high level of customer service.

“Supporting Provizio SEM Scanner users’ work to achieve a zero incidence of preventable pressure injuries in all care settings is our top priority and we look forward to supporting Provizio SEM Scanner users directly to help overcome this challenge,” commented Bruin Biometrics’ CEO, Martin Burns.

“Pressure injuries represent a significant economic challenge for healthcare systems worldwide, and Arjo has extensive experience in both prevention and treatment within this area. We see a growing interest for our other solutions and are fully committed to continue supporting our customers in their efforts to prevent pressure injuries,” says Joacim Lindoff, President & CEO of Arjo.

For more information about Bruin Biometrics, please contact:
Kate Hancock, EVP External Communications, Bruin Biometrics Tel: +447827315347
Email: khancock@bruinbiometrics.com

Media contact details:
Joanna Dodd, Alicia Barkle Rochester PR Group: joanna.dodd@rochesterprgroup.com, alicia.barkle@rochesterprgroup.com 

ABOUT Bruin Biometrics

Bruin Biometrics LLC is a pioneer in modernizing healthcare with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians. Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles, USA.

Photo – https://mma.prnewswire.com/media/2549409/Provizio_SEM_Scanner.jpg
Logo – https://mma.prnewswire.com/media/3604/BRUIN_BIOMETRICS1__LLC_LOGO.jpg

View original content:https://www.prnewswire.co.uk/news-releases/arjo-and-bruin-biometrics-conclude-distribution-agreement-bruin-biometrics-resumes-direct-sales-and-marketing-of-provizio-sem-scanner-302297639.html

Continue Reading

Technology

Opus IVS and Protech Automotive Solutions Announce Collaboration on Industry-Leading ADAS Identification Solution

Published

8 mins ago

on

November 6, 2024

By

DEXTER, Mich., Nov. 6, 2024 /PRNewswire/ — Opus IVS, a global leader in intelligent vehicle support solutions, is pleased to announce a new partnership with Protech Automotive Solutions, the largest national provider of Advanced Driver-Assistance System (ADAS) diagnostic scanning and calibration services, which will enhance Opus IVS’s ADAS MAP (Advanced Driver Assistance Systems Mapping) solution. This collaboration will deliver extensive ADAS identification capabilities, combining the advanced ADAS technologies of both companies – with Opus IVS licensing Protech’s ADAS ID3 technology to bring new innovations to the industry-leading ADAS MAP platform.

The Opus IVS and Protech partnership will create a seamless ADAS identification solution that enables technicians to quickly and accurately identify ADAS systems, empowering repair shops to make well- informed repair and calibration decisions. With Protech Automotive Solutions, the nation’s largest car- side provider, this partnership will offer an enhanced solution to power leading U.S. multi-shop operators (MSOs). Additionally, Opus IVS recently announced that major insurers now recognize ADAS MAP’s accuracy, which leads to increased reimbursement for repair shops and adds significant value for the industry.

“This collaboration between Opus IVS and Protech represents a breakthrough in delivering accessible ADAS insights,” said Brian Herron, CEO of Opus IVS. “By joining forces, we’re building a more powerful ADAS solution for collision shops, allowing them to serve their customers with the highest levels of accuracy and safety.”

Grant LaBarbera, GM and Senior Vice President of Protech, added, “We’re excited to partner with Opus IVS to enhance the industry’s capabilities in ADAS identification. This collaboration brings together the best of both companies’ innovations and will improve the way repair shops approach ADAS, driving greater accuracy, quality and consistency across the industry.”

About Opus IVS
Opus IVS provides diagnostic and programming support to over 50,000 workshops globally. With a suite of solutions for complex repairs and ADAS management, Opus IVS empowers shops to deliver accurate repairs using advanced technology, OE support, and live technician guidance.

About Protech Automotive Solutions
With the largest national footprint of Advanced Driver-Assistance System (ADAS) diagnostic scanning and calibration services, Protech Automotive Solutions is the leading provider of advanced diagnostics, calibrations and ADAS solutions for collision repair shops. Protech is committed to vehicle safety through innovative, reliable ADAS technology and offers expertise that helps automotive service providers keep their customers safe. More than 1,200 Protech technicians, across 41 states and growing, are expertly trained to scan, calibrate and diagnose vehicles during collision, auto glass and mechanical repairs, ensuring that complex systems like ADAS are restored to their proper function.

For more information, please visit www.protechautomotivesolutions.com.

For more information:
Justin Baronoff
Merit Mile
561-362-8888 – office
407-340-2247 – mobile
jbaronoff@meritmile.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/opus-ivs-and-protech-automotive-solutions-announce-collaboration-on-industry-leading-adas-identification-solution-302297790.html

SOURCE Opus IVS

Continue Reading

Technology

Retail Fluent Media Network Announces Strategic Partnership with Save A Lot’s Independent Retail Partners

Published

8 mins ago

on

November 6, 2024

By

Nearly 900 Stores to Utilize RFMN’s Dynamic, Ultra-Bright Digital Window Signs™ for Advertising; Number of Screens Projected to Double by End of Q4, 2024

LITTLE FALLS, N.J., Nov. 6, 2024 /PRNewswire-PRWeb/ — Retail Fluent Media Network (RFMN), a top retail media and ad tech company that caters to independent grocers, mid- to large-scale chain supermarkets, and convenience stores, has revealed a new strategic partnership with Save a Lot’s independent Retail Partners. This partnership includes Save a Lot’s 750 independently owned and operated stores located across 32 states in the United States.

Through this partnership, Save a Lot’s independent Retail Partners will have the opportunity to utilize Digital Window Signs™ to promote weekly sales programs, special events, promotional items, and more. RFMN has already installed 400 digital screens in almost 100 Save a Lot stores, with plans to double the number of active Digital Window Signs™ by Q1, 2025.

“We’re thrilled to partner with Save a Lot’s independent Retail Partners to bring the power of our dynamic Digital Window Signs™ and an industry-leading ad tech platform to their extensive network of stores across the United States,” stated Joni Elmore, Chief Commercial Officer at Retail Fluent Media Network “This collaboration empowers local grocers to enhance their in-store advertising with real-time promotions and elevate engagement with customers and CPG partners. We look forward to giving more stores the opportunity to differentiate themselves in their market with stunning visuals.”

In addition to next-level digital signage, Retail Fluent Media Network provides end-to-end services for Save a Lot’s independent Retail Partners. RFMN manages the content shared by the Save a Lot, working with its vast network of artists and graphic designers, and launching dynamic advertisements through its proprietary ad tech platform to align with each location’s sales and promotions schedule. This allows Save a Lot’s independent Retail Partners to focus on business operations and meeting customer needs.

Retail Fluent Media Network has recently announced its spinoff from Retail Fluent, a prominent retail innovation, design, and décor firm. This decision was made in response to the high demand and growth of the company. RFMN currently owns and operates almost 5,000 Digital Window Signs™ in 28 states, with plans to more than double this number by the end of 2025.

About Retail Fluent Media Network:

Retail Fluent Media Network is a leading retail media and ad tech company for independent grocers, mid- to large-scale chain supermarkets and convenience stores. The company’s digital out-of-home (DOOH) model utilizes ultra-bright LCD and LED screens proven to attract attention to static or video advertisements. Beneficial for both grocers and CPG brands, RFMN’s expanding network already delivers over 50 million impressions weekly and over 200 million monthly to its advertising partners. To partner, advertise, or learn more, visit https://www.retailfluentmedia.com.

Media Contact

Javian Pereira, Fastlane Communications, 1 9736683003, javian@fastlane.co

View original content:https://www.prweb.com/releases/retail-fluent-media-network-announces-strategic-partnership-with-save-a-lots-independent-retail-partners-302296168.html

SOURCE Retail Fluent Media Network

Continue Reading

Trending